​

Indivior Pharmaceuticals Stock (NASDAQ:INDV)

RevenueOwnershipFinancialsChartTranscripts

Previous Close

$32.83

52W Range

$8.64 - $38.00

50D Avg

$34.03

200D Avg

$26.11

Market Cap

$3.85B

Avg Vol (3M)

$2.32M

Beta

1.19

Div Yield

-

INDV Company Profile

Indivior Pharmaceuticals Inc is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September 26, 2014 and is headquartered in North Chesterfield, VA.

Show More

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

1,030

IPO Date

Dec 29, 2014

Website

INDV Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/ServiceDec 25
Reportable Segment$1.24B

Fiscal year ends in Dec 25 | Currency in USD

INDV Financial Summary

Dec 25Dec 24Dec 23
Revenue$1.24B$1.19B$1.09B
Operating Income$262.00M$32.00M$-156.00M
Net Income$210.00M$2.00M$-129.00M
EBITDA$262.00M$84.00M$-99.00M
Basic EPS$1.68$0.02$0.01
Diluted EPS$1.64$0.02$0.01

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts

Q4 25Feb 26, 26 | 8:00 AM
Q3 25Oct 30, 25 | 8:00 AM
Q2 25Aug 01, 25 | 8:00 AM

Peer Comparison

TickerCompany
HNGEHinge Health, Inc.
ADMAADMA Biologics, Inc.
VKTXViking Therapeutics, Inc.
CRNXCrinetics Pharmaceuticals, Inc.
SUPNSupernus Pharmaceuticals, Inc.
PRAXPraxis Precision Medicines, Inc.
ACADACADIA Pharmaceuticals Inc.
OPCHOption Care Health, Inc.
AMRXAmneal Pharmaceuticals, Inc.
LNTHLantheus Holdings, Inc.